A RANDOMIZED CONTROLLED INTERVENTIONAL STUDY COMPARING THE EFFECTIVENESS OF CENTCHROMAN AND NORETHISTERONE IN THE TREATMENT OF HEAVY MENSTRUAL BLEEDING - NI

ANGANA DAS0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

研究概览

暂无简介。

•1.Women with heavy menstrual bleeding with or without associated dysmenorrhea or chronic pelvic pain
•2.All women with histologically proven endometrial hyperplasia without atypia or any other benign endometrial pathology
•3.Fibroid uterus less than 12 weeks in size not distorting the endometrial cavity
•4.Adenomyosis
•5.All women with medical or surgical high risk factors making the subjects unsuitable for surgery

•1.Active genital infection
•2.Suspicion of pregnancy or malignancy
•3.Submucosal fibroid distorting the endometrial cavity
•4.Uterine fibroids more than 5 centimeters in size
•5.Atypical endometrial hyperplasia or malignancy
•6.Abnormal cervical cytology and malignancy
•7.Haematological disease or abnormal coagulopathy
•8.History of arterial or venous thromboembolic disorders
•9.Women who want to conceive
•10.Women who are not willing to give consent for the study
•11.Patients with polycystic ovarian disease or history of jaundice or hepatic impairment or severe allergy or tuberculosis or renal impairment or undiagnosed vaginal bleeding or breast cancer

发起方

ANGANA DAS